Skip to main content

DA32 Life Science Tech Acquisition Corp.

DALSDelisted Jul 28, 2023
Industry
Blank Checks
SEC CIK
0001863294

DA32 Life Science Tech Acquisition Corp. was delisted on Jul 28, 2023; its insiders filed their last Form 4 on Aug 10, 2023; 51 institutions reported holding it in 13F filings for Q2 2023, worth $174.9M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding DA32 Life Science Tech Acquisition Corp. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of DALS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders45143−1
Shares15.5M75.9K15.5M+102.2K (+0.7%)
Value$150.2M$736.0K$150.9M+$1.49M (+1.0%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held DA32 Life Science Tech Acquisition Corp. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to DALS in Q3 2022
InstitutionSharesValue% of portfolio
Highbridge Capital Management LLC90,891$881.0K0.01%
Exos TFP Holdings LLC75,704$737.0K0.34%
Karpus Management, Inc.53,950$525.0K0.02%
Elequin Capital LP1,483$14.0K0.01%

Sold out (5)

Institutions that held DA32 Life Science Tech Acquisition Corp. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of DALS in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Alyeska Investment Group, L.P.500,000$4.84M
Berkley W R Corp157,016$1.52M
CSS LLC149,412$1.45M
Schonfeld Strategic Advisors LLC13,389$130.0K
Cheyne Capital Management (UK) LLP10,000$97.0K

Not filed for Q3 2022 yet (1)

Institutions that held DA32 Life Science Tech Acquisition Corp. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DALS in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Exos Asset Management LLC75,929$736.0K